METABOLIC REPROGRAMMING IN CANCER THERAPY

Cancer cells exhibit a distinct reprogramming in their metabolic pathways, enabling them to proliferate and survive in the hostile tumor microenvironment. This metabolic adaptation is characterized by increased glucose uptake, enhanced glycolysis, and altered mitochondrial function. Understanding these metabolic alterations is crucial for developin